These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17673057)

  • 1. Regurgitation of esophageal mucosa.
    Gesundheit B; Resnick IB
    Mayo Clin Proc; 2007 Aug; 82(8):907. PubMed ID: 17673057
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrospective study of the digestive tract mucositis derived from myeloablative and non-myeloablative/reduced-intensity conditionings with busulfan in hematopoietic cell transplantation patient.
    Eduardo FP; Bezinelli LM; Gobbi M; Rosin FCP; Carvalho DLC; Ferreira MH; da Silva CC; Hamerschlak N; Corrêa L
    Support Care Cancer; 2019 Mar; 27(3):839-848. PubMed ID: 30109488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence and severity of oral mucositis in allogeneic stem cell transplantation after conditioning with treosulfan and fludarabine.
    Heli U; Eeva J; Anne N; Tapani R; Liisa V
    Eur J Haematol; 2012 Jan; 88(1):87-8. PubMed ID: 22103782
    [No Abstract]   [Full Text] [Related]  

  • 4. New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2.
    Chae YS; Sohn SK; Kim JG; Cho YY; Moon JH; Shin HJ; Chung JS; Cho GJ; Yang DH; Lee JJ; Kim YK; Kim HJ
    Bone Marrow Transplant; 2007 Sep; 40(6):541-7. PubMed ID: 17637692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients.
    Herbers AH; de Haan AF; van der Velden WJ; Donnelly JP; Blijlevens NM
    Transpl Infect Dis; 2014 Apr; 16(2):279-85. PubMed ID: 24621081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of myeloablative conditioning regimens: busulfan plus cyclophosphamide versus busulfan plus fludarabine.
    Lee JH; Joo YD; Kim H; Ryoo HM; Kim MK; Lee GW; Lee JH; Lee WS; Park JH; Bae SH; Hyun MS; Kim DY; Kim SD; Min YJ; Lee KH
    J Clin Oncol; 2013 Feb; 31(6):701-9. PubMed ID: 23129746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4).
    Patel P; Sweiss K; Nimmagadda S; Gao W; Rondelli D
    Bone Marrow Transplant; 2011 Oct; 46(10):1326-30. PubMed ID: 21132027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major.
    Bernardo ME; Zecca M; Piras E; Vacca A; Giorgiani G; Cugno C; Caocci G; Comoli P; Mastronuzzi A; Merli P; La Nasa G; Locatelli F
    Br J Haematol; 2008 Nov; 143(4):548-51. PubMed ID: 18986389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive toxicity of once daily i.v. BU, melphalan and thiotepa followed by auto SCT on patients with non-Hodgkin's lymphoma.
    Lee SC; Kim SJ; Lee DH; Kim WS; Suh C; Won JH
    Bone Marrow Transplant; 2010 Apr; 45(4):801-2. PubMed ID: 19767780
    [No Abstract]   [Full Text] [Related]  

  • 10. Should busulfan-containing regimen be avoided for young female patients undergoing hematopoietic stem cell transplantation?
    Okuda S; Sato M; Terasako K; Kako S; Oshima K; Kanda Y
    Bone Marrow Transplant; 2009 Feb; 43(3):261-2. PubMed ID: 18794867
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of zinc sulfate in the prevention of high-dose chemotherapy-induced mucositis: a double-blind, randomized, placebo-controlled study.
    Mansouri A; Hadjibabaie M; Iravani M; Shamshiri AR; Hayatshahi A; Javadi MR; Khoee SH; Alimoghaddam K; Ghavamzadeh A
    Hematol Oncol; 2012 Mar; 30(1):22-6. PubMed ID: 21692101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation.
    Hong JY; Choi MK; Kim DH; Kim SJ; Kim K; Kim WS; Chung CW; Kim HO; Min YH; Jang JH
    Transplant Proc; 2010 Nov; 42(9):3723-8. PubMed ID: 21094846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine-induced severe necrotizing leukoencephalopathy in pediatric hematopoietic cell transplantation.
    Helton KJ; Patay Z; Triplett BM
    Bone Marrow Transplant; 2013 May; 48(5):729-31. PubMed ID: 23085831
    [No Abstract]   [Full Text] [Related]  

  • 14. Treosulphan-based radiation-free myeloablative conditioning for allogeneic transplant in infant acute lymphoblastic leukaemia.
    Corker E; Astwood E; Williams J; Vora A
    Br J Haematol; 2012 Oct; 159(1):104-6. PubMed ID: 22804487
    [No Abstract]   [Full Text] [Related]  

  • 15. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT.
    Mickelson DM; Sproat L; Dean R; Sobecks R; Rybicki L; Kalaycio M; Pohlman B; Sweetenham J; Andresen S; Bolwell B; Copelan EA
    Bone Marrow Transplant; 2011 Jan; 46(1):84-9. PubMed ID: 20305699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of graft failure in unrelated cord blood transplantation using a reduced-intensity preparative regimen consisting of fludarabine and melphalan.
    Narimatsu H; Watanabe M; Kohno A; Sugimoto K; Kuwatsuka Y; Uchida T; Murata M; Miyamura K; Morishita Y;
    Bone Marrow Transplant; 2008 Apr; 41(8):753-6. PubMed ID: 18195683
    [No Abstract]   [Full Text] [Related]  

  • 18. Preservation of fertility in women undergoing reduced-intensity conditioning allogeneic transplantation with a fludarabine-based regime.
    Papageorgiou SG; Ahmed O; Narvekar N; Davies M; Kottaridis PD
    Transplantation; 2012 Sep; 94(5):e29-30. PubMed ID: 22955169
    [No Abstract]   [Full Text] [Related]  

  • 19. Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients.
    Iravani M; Evazi MR; Mousavi SA; Shamshiri AR; Tavakoli M; Ashouri A; Samiee S; Chahardovali B; Alimoghaddam K; Ghaffari SH; Ghavamzadeh A
    Bone Marrow Transplant; 2007 Jul; 40(2):105-10. PubMed ID: 17468775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy.
    Jamy O; Arora S; Meredith R; Salzman D; Di Stasi A; Minagawa K; Mineishi S; Saad A
    Bone Marrow Transplant; 2022 Oct; 57(10):1597-1599. PubMed ID: 35810256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.